ClinicalTrials.gg
RecruitingNCT05492266Updated Jul 20, 2026

Expiratory Muscle Strength Training for Hypernasal Speech in Children

An interventional study of Expiratory Muscle Strength Training and Maintenance Training in Velopharyngeal Insufficiency, Velopharyngeal Incompetence Due to Cleft Palate and Inadequate Velopharyngeal Closure, sponsored by Noel Jabbour. Recruiting at 1 site in United States. Open to participants aged 5 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Noel Jabbour · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
5 Years to 17 Years
Sex
All
01

Study summary

When the soft palate does not move enough because of a cleft palate or for unknown reasons, this can lead to a speech difference called velopharyngeal insufficiency. The purpose of this research study is to test if soft palate exercises using a hand help breathing device will help improve the ability of the soft palate to close the area between the throat and nose and help improve speech.

Read the detailed description

The objective of this study is to examine the feasibility and efficacy of expiratory muscle strength training to improve velopharyngeal closure in patients with velopharyngeal dysfunction and nasal air emissions. A single-arm trial will be conducted at a cleft craniofacial center at a tertiary children's hospital. Patients will perform Expiratory Muscle Strength Training for 6 to 8 weeks. Patients with reductions in nasal resonance during this time will be further randomized to EMST maintenance training for 6 months or no exercises.

02

Conditions studied

  • Velopharyngeal Insufficiency
  • Velopharyngeal Incompetence Due to Cleft Palate
  • Inadequate Velopharyngeal Closure
  • Palatopharyngeal Incompetence
  • Hypernasality

Keywords

  • Cleft Palate
  • Speech Intelligibility
03

In context

Velopharyngeal Insufficiency

20 studies on the registry are indexed under Velopharyngeal Insufficiency; 9 are open to participants now.

This study's planned enrollment of 30 is above the median of 20 across 13 interventional studies indexed under Velopharyngeal Insufficiency.

Browse Velopharyngeal Insufficiency studies →

Lead sponsor

Noel Jabbour is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Score of 2 or greater on the nasality/resonance domain of the Pittsburgh Weighted Speech Scale
  • Ages 5-17 years

Exclusion criteria

Exclusion Criteria:

  • CAPS-A-AM hypernasality score \<2
  • Previous speech surgery (e.g. palatoplasty or pharyngeal flap for speech)
  • Speech surgery scheduled within the next 56 days
  • Unable or unwilling to perform the tests and exercises outlined in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Expiratory Muscle Strength Training + No Maintenance Training

    These participants completed 6-8 weeks of exercises with EMST-150. They had improvement in their CAPS-A hypernasality rating of 1 point or more and were randomized to complete 6 months of no maintenance training.

    Device: Expiratory Muscle Strength Training

  • Experimental
    Expiratory Muscle Strength Training + Maintenance Training

    These participants completed 6-8 weeks of exercises with EMST-150. They had improvement in their CAPS-A hypernasality rating of 1 point or more and were randomized to complete 6 months of maintenance training.

    Device: Expiratory Muscle Strength Training · Device: Maintenance Training

  • Experimental
    Expiratory Muscle Strength Training

    These participants completed 6-8 weeks of exercises with EMST-150. They did not have improvement in their CAPS-A hypernasality rating of 1 point or more and ended active study participation after the initial 6-8 weeks of exercises.

    Device: Expiratory Muscle Strength Training

Interventions

  • DeviceExpiratory Muscle Strength Training

    At visit 1, participants will be block randomized based on PWSS score (5-6 or 7+) to Expiratory Muscle Strength Training (EMST) for 6 to 8 weeks or no exercises. Participants in the EMST-150 group will perform 5 sets of 5 resistive expirations once a day with a 10-15 second rest between each repetition and a 1-2 minute rest between each set of 5 repetitions.

    Also known as: EMST-150

  • DeviceMaintenance Training

    At visit 2, participants with improved (decreased) CAPS-A hypernasality rating of 1 or more points, for whom the family and/or surgeon is not currently considering surgical intervention for VPI, will be further randomized to continue "maintenance" EMST exercises or no exercises for 6 months. Participants in the "maintenance" group will complete 3-5 sessions exercise sessions each week (rather than daily training), with 2 sets of 5 resistive expirations (rather than 5 sets)

06

What researchers measure

Primary outcomes

  1. Change in nasalance scores after 6-8 weeks of exercises compared with baseline

    Percent change in nasalance measured during nasometry

    Time frame: Baseline and 6-8 weeks

  2. Change in perceptual speech symptoms of velopharyngeal dysfunction following 6-8 weeks of exercises compared with baseline

    Perceptual symptoms of velopharyngeal incompetence measured using the CAPS-A-AM hypernasality score, on a scale of 0-4. 0 indicates nasality that is normal for the region, 1 (borderline/minimal) suggests a minimal or inconsistent increase in nasal resonance, 2 (mild) implies hypernasality that is evident on vowels with a high tongue posture, 3 (moderate) indicates hypernasality that is perceived across all vowels, and 4 (severe) signifies that hypernasality is evident in voiced consonants and all vowels.

    Time frame: Baseline and 6-8 weeks

  3. Change in oral pressure following 6-8 weeks of exercises compared with baseline

    Percent change in oral pressure achieved when blowing through the EMST-150

    Time frame: Baseline and 6-8 weeks

  4. Change in velopharyngeal flutter following 6-8 weeks of exercises compared with baseline

    Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150

    Time frame: Baseline and 6-8 weeks

  5. Change in oral pressure decay following 6-8 weeks of exercises compared with baseline

    Ratio of the magnitude of oral pressure decay when blowing through the EMST-150

    Time frame: Baseline and 6-8 weeks

Secondary outcomes

  1. Change in VELO questionnaire scores following 6-8 weeks of exercises compared with baseline

    Percent change in Velopharyngeal Insufficiency (VPI) Effects on Life Outcomes (VELO) scores. Scores range from 0 - 100, with 100 representing the highest QOL

    Time frame: Baseline and 6-8 weeks

  2. Resolution of type B tympanogram following 6-8 weeks of exercises compared with baseline.

    Percentage of participants with a change in tympanogram type from type B (flat) to type A (normal middle ear function).

    Time frame: Baseline and 6-8 weeks

  3. Resolution of type C tympanogram following 6-8 weeks of exercises compared with baseline.

    Percentage of participants with a change in tympanogram type from type C (negative pressure) to type A (normal middle ear function).

    Time frame: Baseline and 6-8 weeks

  4. Resolution of effusion following 6-8 weeks of exercises compared with baseline.

    Percentage of participants with resolution of middle ear effusion based on otoscopy.

    Time frame: Baseline and 6-8 weeks

  5. Resolution of retraction following 6-8 weeks of exercises compared with baseline.

    Percentage of participants with resolution of tympanic membrane retraction based on otoscopy

    Time frame: Baseline and 6-8 weeks

Other outcomes

  1. Change in nasalance scores after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

    Percent change in nasalance measured during nasometry

    Time frame: 6-8 weeks and 8 months

  2. Change in perceptual speech symptoms of velopharyngeal dysfunction after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

    Perceptual symptoms of velopharyngeal incompetence measured using the CAPS-A-AM hypernasality score, on a scale of 0-4. 0 indicates nasality that is normal for the region, 1 (borderline/minimal) suggests a minimal or inconsistent increase in nasal resonance, 2 (mild) implies hypernasality that is evident on vowels with a high tongue posture, 3 (moderate) indicates hypernasality that is perceived across all vowels, and 4 (severe) signifies that hypernasality is evident in voiced consonants and all vowels.

    Time frame: 6-8 weeks and 8 months

  3. Change in oral pressure after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

    Percent change in pressure achieved when blowing through the EMST-150

    Time frame: 6-8 weeks and 8 months

  4. Change in velopharyngeal flutter after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

    Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150

    Time frame: 6-8 weeks and 8 months

  5. Change in oral pressure decay after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

    Ratio of the magnitude of oral pressure decay when blowing through the EMST-150

    Time frame: 6-8 weeks and 8 months

  6. Prevalence of surgical intervention

    Percentage of patients undergoing surgical intervention for speech symptoms within the 1 year following enrollment

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • UPMC Children's Hospital of Pittsburgh
    Pittsburgh, Pennsylvania 15224, United States
    Recruiting
    • Amber D Shaffer, PhD · Contactshafferad@upmc.edu · 412-692-6874
    • Marina V Rushchak, BA · Contactrushchakmv4@upmc.edu · 412-692-9879
    • Cuneyt Alper, MD · Sub investigator
    • Fendi Obuekwe · Sub investigator
    • Matthew Ford, MS · Sub investigator
    • Jesse Goldstein, MD · Sub investigator
    • Nancy Gauvin, PhD · Sub investigator
    • Noel Jabbour, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data (IPD) that underlie the results reported in a publication may be shared, after de-identification.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Beginning 1 year after publication of summary data. Ending 5 years after publication.

Access criteria: IPD will be shared with researchers who provide a methodologically sound proposal. IPD to be shared will include that necessary to achieve the aims in the approved proposal. Proposals should be directed to shafferad@upmc.edu. To gain access, data requestors will need to sign data access agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for May 2027, 26 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 4, 2022
First posted
Aug 8, 2022
StartActual
Mar 3, 2025
Primary completionEst.
May 2027
CompletionEst.
Nov 2027
Last update
Jul 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05492266
Lead sponsor
Noel Jabbour
Responsible party
Noel Jabbour (Associate Professor, University of Pittsburgh) — Sponsor-investigator
First posted
Aug 8, 2022
Start date
Mar 3, 2025
Primary completion
May 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Jul 20, 2026

Study contacts

Amber D Shaffer, PhD
Contact
shafferad@upmc.edu
412-692-6874
Noel Jabbour, MD
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion